These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3971390)

  • 41. Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience.
    Batra A; Patel B; Addison D; Baldassarre LA; Desai N; Weintraub N; Deswal A; Hussain Z; Brown SA; Ganatra S; Agarwala V; Parikh PM; Fradley M; Ghosh A; Guha A
    Open Heart; 2021 Dec; 8(2):. PubMed ID: 34952868
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Strong delayed-action pervincamine in general medicine].
    Warembourg H; Ketelers JY
    Lille Med; 1975 Apr; 20(4):424-7. PubMed ID: 1152596
    [No Abstract]   [Full Text] [Related]  

  • 43. Vocal fold palsy following vinca alkaloid treatment.
    Burns BV; Shotton JC
    J Laryngol Otol; 1998 May; 112(5):485-7. PubMed ID: 9747483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cardiac toxicity of vinca alkaloids. Critical review of the literature].
    Aymard JP; Ferry R; Netter P; Balaud A; Streiff F
    Therapie; 1985; 40(5):361-4. PubMed ID: 3913049
    [No Abstract]   [Full Text] [Related]  

  • 45. Acute bronchospasm after a vinca alkaloid in patients previously treated with mitomycin.
    Dyke RW
    N Engl J Med; 1984 Feb; 310(6):389. PubMed ID: 6690968
    [No Abstract]   [Full Text] [Related]  

  • 46. [Bladder hyporeflexia caused by vinca alkaloids].
    Pérez Pérez J; Richart López A; González Enguita C; Cabrera Pérez J; Bernacer Borja M; Vela Navarrete R
    Actas Urol Esp; 2000 Mar; 24(3):275-7. PubMed ID: 10870240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostaglandin F2 alpha in the treatment of vinca alkaloid-induced ileus.
    Saito H; Yamamoto T; Kimura M; Shimokata K
    Am J Med; 1993 Nov; 95(5):549-51. PubMed ID: 8238076
    [No Abstract]   [Full Text] [Related]  

  • 48. Hypertension in Cardio-Oncology Clinic: an update on etiology, assessment, and management.
    Askarinejad A; Alizadehasl A; Jolfayi AG; Adimi S
    Cardiooncology; 2023 Dec; 9(1):46. PubMed ID: 38087384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics: What Is the Evidence?
    Kamphuis JAM; Linschoten M; Cramer MJ; Gort EH; van Rhenen A; Asselbergs FW; Doevendans PA; Teske AJ
    JACC CardioOncol; 2019 Dec; 1(2):280-290. PubMed ID: 34396190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative assessment of cardiovascular autonomic impairment in cancer survivors: a single center case series.
    Noor B; Akhavan S; Leuchter M; Yang EH; Ajijola OA
    Cardiooncology; 2020; 6():11. PubMed ID: 32742722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer.
    Zaborowska-Szmit M; Krzakowski M; Kowalski DM; Szmit S
    J Clin Med; 2020 Apr; 9(5):. PubMed ID: 32349387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular Autonomic Dysfunction in Patients with Cancer.
    Coumbe BGT; Groarke JD
    Curr Cardiol Rep; 2018 Jul; 20(8):69. PubMed ID: 29971575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RE: Elucidating Pretreatment Cognitive Impairment in Breast Cancer Patients: The Impact of Cancer-Related Post-traumatic Stress.
    Sepehry AA; Tyldesley S; Davis MK; Simmons C; Rauscher A; Lang DJ
    J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27075855
    [No Abstract]   [Full Text] [Related]  

  • 54. Cavernous angioma after chemotherapy for desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia.
    Yamasaki F; Takayasu T; Nosaka R; Kawaguchi H; Sugiyama K; Kobayashi M; Kurisu K
    Childs Nerv Syst; 2016 Feb; 32(2):395-8. PubMed ID: 26231569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer chemotherapy and cardiac arrhythmias: a review.
    Tamargo J; Caballero R; Delpón E
    Drug Saf; 2015 Feb; 38(2):129-52. PubMed ID: 25577497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autonomic dysfunction in patients with advanced cancer; prevalence, clinical correlates and challenges in assessment.
    Stone CA; Kenny RA; Nolan B; Lawlor PG
    BMC Palliat Care; 2012 Mar; 11():3. PubMed ID: 22379978
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatments for astrocytic tumors in children: current and emerging strategies.
    Burzynski SR
    Paediatr Drugs; 2006; 8(3):167-78. PubMed ID: 16774296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.
    Pai VB; Nahata MC
    Drug Saf; 2000 Apr; 22(4):263-302. PubMed ID: 10789823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Autonomic disorders in polyneuropathies].
    Hilz MJ; Dütsch M; Neundörfer B
    Med Klin (Munich); 1998 Sep; 93(9):533-40. PubMed ID: 9792019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A review of the drug treatment of cachexia associated with cancer.
    Gagnon B; Bruera E
    Drugs; 1998 May; 55(5):675-88. PubMed ID: 9585863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.